thietane uridine derivatives (Janssen Pharmaceutica)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namethietane uridine derivatives (Janssen Pharmaceutica)
Drug Alias Namenucleoside inhibitor (Janssen Pharmaceutica)nucleotide inhibitors (Janssen Pharmaceutica)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHepatitis CDengueAlphavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJanssen Pharmaceutica NV
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Pharmaceutica NV
Inactive CompaniesN/A
Active IndicationsHepatitis CDengueAlphavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A